UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 4.663

Sortiert nach

Trends in human papillomavirus (HPV) vaccination initiation among adolescents aged 13-17 by metropolitan statistical area (MSA) status, National Immunization Survey - Teen, 2013 - 2017

Human vaccines & immunotherapeutics, 2020-03, Vol.16 (3), p.554-561

2020

Link zum Volltext

Verfügbarkeit prüfen

Oral Human Papillomavirus (HPV) Infection—Are There Implications for HPV Vaccination?

The Journal of infectious diseases, 2010-02, Vol.201 (3), p.478-478

2010

Link zum Volltext

Verfügbarkeit prüfen

CD40 Accelerates the Antigen-Specific Stem-Like Memory CD8 + T Cells Formation and Human Papilloma Virus (HPV)-Positive Tumor Eradication

Frontiers in immunology, 2020-05, Vol.11, p.1012-1012

2020

Link zum Volltext

Verfügbarkeit prüfen

Resolution of novel human papillomavirus-induced warts after HPV vaccination

Emerging infectious diseases, 2014-01, Vol.20 (1), p.142-145

2014

Link zum Volltext

Verfügbarkeit prüfen

Immunotherapy of a human papillomavirus (HPV) type 16 E7‐expressing tumour by administration of fusion protein comprising Mycobacterium bovis bacille Calmette–Guérin (BCG) hsp65 and HPV16 E7

Clinical and experimental immunology, 2000-08, Vol.121 (2), p.216-225

2000

Link zum Volltext

Verfügbarkeit prüfen

Chinese mothers' intention to vaccinate daughters against human papillomavirus (HPV), and their vaccine preferences: a study in Fujian Province

Human vaccines & immunotherapeutics, 2021-01, Vol.17 (1), p.304-315

2021

Link zum Volltext

Verfügbarkeit prüfen

Genotype-Specific Persistence of Genital Human Papillomavirus (HPV) Infections in Women Followed for 6 Years in the Finnish Family HPV Study

The Journal of infectious diseases, 2010-08, Vol.202 (3), p.436-444

2010

Link zum Volltext

Verfügbarkeit prüfen

Presence of Human Papillomavirus (HPV) Apolipoprotein B Messenger RNA Editing, Catalytic Polypeptide-Like 3 (APOBEC)-Related Minority Variants in HPV-16 Genomes From Anal and Cervical Samples but Not in HPV-52 and HPV-58

The Journal of infectious diseases, 2018-08, Vol.218 (7), p.1027-1036

2018

Link zum Volltext

Verfügbarkeit prüfen

Progression from human papillomavirus (HPV) infection to cervical lesion or clearance in women (18-25 years): Natural history study in the control arm subjects of AS04-HPV-16/18 vaccine efficacy study in China between 2008 and 2016

Expert review of vaccines, 2022-03, Vol.21 (3), p.407-413

2022

Link zum Volltext

Verfügbarkeit prüfen

Veteran Women Living With Human Immunodeficiency Virus Have Increased Risk of Human Papillomavirus (HPV)-Associated Genital Tract Cancers

Clinical infectious diseases, 2021-05, Vol.72 (9), p.e359-e366

2021

Link zum Volltext

Verfügbarkeit prüfen

Human papillomavirus (HPV) insertional mutation as a dynamic & specific tumour biomarker in HPV-associated carcinoma

Indian journal of medical research (New Delhi, India : 1994), 2015-11, Vol.142 (5), p.507

Sastre-Garau, Xavier

2015

Link zum Volltext

Verfügbarkeit prüfen

Cellular Immune Responses to Human Papillomavirus (HPV)-16 L1 in Healthy Volunteers Immunized with Recombinant HPV-16 L1 Virus-Like Particles

The Journal of infectious diseases, 2003-07, Vol.188 (2), p.327-338

2003

Link zum Volltext

Verfügbarkeit prüfen

Risk Factors for Subsequent Cervicovaginal Human Papillomavirus (HPV) Infection and the Protective Role of Antibodies to HPV-16 Virus-Like Particles

The Journal of infectious diseases, 2002-09, Vol.186 (6), p.737-742

2002

Link zum Volltext

Verfügbarkeit prüfen

Human Papillomavirus (HPV) Vaccine Uptake and the Willingness to Receive the HPV Vaccination among Female College Students in China: A Multicenter Study

Vaccines (Basel), 2020-01, Vol.8 (1), p.31

2020

Link zum Volltext

Verfügbarkeit prüfen

Changes in Cervical Human Papillomavirus (HPV) Prevalence at a Youth Clinic in Stockholm, Sweden, a Decade After the Introduction of the HPV Vaccine

Frontiers in cellular and infection microbiology, 2019-03, Vol.9, p.59-59

2019

Link zum Volltext

Verfügbarkeit prüfen

Transcriptional control of human papillomavirus (HPV) oncogene expression: composition of the HPV type 18 upstream regulatory region

Journal of Virology, 1993-11, Vol.67 (11), p.6476-6486

1993

Link zum Volltext

Verfügbarkeit prüfen

Epidemiologic Determinants of Seroreactivity to Human Papillomavirus (HPV) Type 16 Virus-Like Particles in Cervical HPV-16 DNA—Positive and —Negative Women

The Journal of infectious diseases, 1996-11, Vol.174 (5), p.937-943

1996

Link zum Volltext

Verfügbarkeit prüfen

Control of Epstein-Barr Virus (EBV) in the Oral Cavity Is Associated With Persistence of Oral Human Papillomavirus (HPV)16/18 Among Men From the HPV Infection in Men Study

The Journal of infectious diseases, 2023-01, Vol.227 (2), p.256-260

2023

Link zum Volltext

Verfügbarkeit prüfen

Prevalence and human papillomavirus (HPV) genotype distribution in Suzhou, China

Human vaccines & immunotherapeutics, 2023-08, Vol.19 (2), p.2241309-2241309

2023

Link zum Volltext

Verfügbarkeit prüfen

The association between human leukocyte antigen (HLA)-G polymorphisms and human papillomavirus (HPV) infection in Inuit women of northern Quebec

Human immunology, 2013-12, Vol.74 (12), p.1610-1615

2013

Link zum Volltext

Verfügbarkeit prüfen

Factors Associated With Persistence and Clearance of High-Risk Oral Human Papillomavirus (HPV) Among Participants in the HPV Infection in Men (HIM) Study

Clinical infectious diseases, 2021-11, Vol.73 (9), p.e3227-e3234

2021

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of Human Papillomavirus (HPV) and HPV Type Distribution in Penile Samples in Young Men in Denmark: Results 10 Years After Implementation of a Girls-Only HPV Vaccination Program

The Journal of infectious diseases, 2024-03

2024

Link zum Volltext

Verfügbarkeit prüfen

Review of human papillomavirus (HPV) burden and HPV vaccination for gay, bisexual, and other men who have sex with men and transgender women in the United States

Human vaccines & immunotherapeutics, 2022-12, Vol.18 (1), p.2016007-2016007

2022

Link zum Volltext

Verfügbarkeit prüfen

Human Papillomavirus (HPV) Vaccine Effectiveness and Potential Herd Immunity for Reducing Oncogenic Oropharyngeal HPV-16 Prevalence in the United Kingdom: A Cross-sectional Study

Clinical infectious diseases, 2019-09, Vol.69 (8), p.1296-1302

2019

Link zum Volltext

Verfügbarkeit prüfen

The association between maternal human papillomavirus (HPV) experiences and HPV vaccination of their children

Human vaccines & immunotherapeutics, 2021-04, Vol.17 (4), p.1000-1005

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 4.663

Suche als RSS-Feed

Aktive Filter

KollektionFactiva

SprachePortugiesisch

ThemaHuman Papillomavirus

ThemaMiddle Aged

ThemaImmunology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(3.938)
Mit Volltextzugriff
(3.723)

Publikationsform

Sprache

7 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(3.937)
Life Sciences & Biomedicine
(3.871)
Humans
(2.511)
Female
(1.141)
Vaccines
(996)
Microbiology
(857)
Medicine, Research & Experimental
(855)
Research & Experimental Medicine
(855)
Infectious Diseases
(852)
Animals
(784)
Vaccination
(646)
Oncology
(613)
Cancer
(523)
Virology
(509)
Biotechnology & Applied Microbiology
(499)
Immunization
(496)
Review
(494)
Biological And Medical Sciences
(486)
Infections
(437)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Human Vaccines & Immunotherapeutics
(464)
Vaccine
(376)
Vaccines
(316)
Expert Review Of Vaccines
(177)
International Journal Of Std & Aids
(157)
Journal Of Virology
(135)
The Journal Of Infectious Diseases
(124)
Infectious Agents And Cancer
(94)
Oncoimmunology
(72)
Frontiers In Immunology
(54)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Trends in human papillomavirus (HPV) vaccination initiation among adolescents aged 13-17 by metropolitan statistical area (MSA) status, National Immunization Survey - Teen, 2013 - 2017

Oral Human Papillomavirus (HPV) Infection—Are There Implications for HPV Vaccination?

CD40 Accelerates the Antigen-Specific Stem-Like Memory CD8 + T Cells Formation and Human Papilloma Virus (HPV)-Positive Tumor Eradication

Resolution of novel human papillomavirus-induced warts after HPV vaccination

Immunotherapy of a human papillomavirus (HPV) type 16 E7‐expressing tumour by administration of fusion protein comprising Mycobacterium bovis bacille Calmette–Guérin (BCG) hsp65 and HPV16 E7

Chinese mothers' intention to vaccinate daughters against human papillomavirus (HPV), and their vaccine preferences: a study in Fujian Province

Genotype-Specific Persistence of Genital Human Papillomavirus (HPV) Infections in Women Followed for 6 Years in the Finnish Family HPV Study

Presence of Human Papillomavirus (HPV) Apolipoprotein B Messenger RNA Editing, Catalytic Polypeptide-Like 3 (APOBEC)-Related Minority Variants in HPV-16 Genomes From Anal and Cervical Samples but Not in HPV-52 and HPV-58

Progression from human papillomavirus (HPV) infection to cervical lesion or clearance in women (18-25 years): Natural history study in the control arm subjects of AS04-HPV-16/18 vaccine efficacy study in China between 2008 and 2016

Veteran Women Living With Human Immunodeficiency Virus Have Increased Risk of Human Papillomavirus (HPV)-Associated Genital Tract Cancers

Human papillomavirus (HPV) insertional mutation as a dynamic & specific tumour biomarker in HPV-associated carcinoma

Cellular Immune Responses to Human Papillomavirus (HPV)-16 L1 in Healthy Volunteers Immunized with Recombinant HPV-16 L1 Virus-Like Particles

Risk Factors for Subsequent Cervicovaginal Human Papillomavirus (HPV) Infection and the Protective Role of Antibodies to HPV-16 Virus-Like Particles

Human Papillomavirus (HPV) Vaccine Uptake and the Willingness to Receive the HPV Vaccination among Female College Students in China: A Multicenter Study

Changes in Cervical Human Papillomavirus (HPV) Prevalence at a Youth Clinic in Stockholm, Sweden, a Decade After the Introduction of the HPV Vaccine

Transcriptional control of human papillomavirus (HPV) oncogene expression: composition of the HPV type 18 upstream regulatory region

Epidemiologic Determinants of Seroreactivity to Human Papillomavirus (HPV) Type 16 Virus-Like Particles in Cervical HPV-16 DNA—Positive and —Negative Women

Control of Epstein-Barr Virus (EBV) in the Oral Cavity Is Associated With Persistence of Oral Human Papillomavirus (HPV)16/18 Among Men From the HPV Infection in Men Study

Prevalence and human papillomavirus (HPV) genotype distribution in Suzhou, China

The association between human leukocyte antigen (HLA)-G polymorphisms and human papillomavirus (HPV) infection in Inuit women of northern Quebec

Factors Associated With Persistence and Clearance of High-Risk Oral Human Papillomavirus (HPV) Among Participants in the HPV Infection in Men (HIM) Study

Prevalence of Human Papillomavirus (HPV) and HPV Type Distribution in Penile Samples in Young Men in Denmark: Results 10 Years After Implementation of a Girls-Only HPV Vaccination Program

Review of human papillomavirus (HPV) burden and HPV vaccination for gay, bisexual, and other men who have sex with men and transgender women in the United States

Human Papillomavirus (HPV) Vaccine Effectiveness and Potential Herd Immunity for Reducing Oncogenic Oropharyngeal HPV-16 Prevalence in the United Kingdom: A Cross-sectional Study

The association between maternal human papillomavirus (HPV) experiences and HPV vaccination of their children

Aktive Filter

Suchergebnisse filtern